Giving albumin increases mortality in critically ill patients
The licensed indications for use of human albumin are the emergency
treatment of shock, acute management of burns, and clinical situations
associated with hypoproteinaemia. However, a systematic review of
randomised controlled trials by the Cochrane Injuries Group Albumin
Reviewers (p 235) showed that albumin administration results in six
extra deaths for every 100 patients treated. The authors call for an
urgent review of the use of human albumin solution in critically ill
patients.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Human albumin administration in critically ill patients: systematic review of randomised controlled trials • Why albumin may not work
- Cochrane Injuries Group Albumin Reviewers and Cochrane Injuries Group Albumin Reviewers
BMJ 1998 317: 235-240.[Abstract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Find similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
